Stockholders' Equity Attributable to Parent in USD of INNOVATIVE MEDTECH, INC. from Q3 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Innovative Medtech, Inc. quarterly Stockholders' Equity Attributable to Parent history and change rate from Q3 2010 to Q1 2025.
  • Innovative Medtech, Inc. Stockholders' Equity Attributable to Parent for the quarter ending 31 Mar 2025 was -$4.89M, a 255% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

INNOVATIVE MEDTECH, INC. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 -$4.89M -$3.52M -255% 31 Mar 2025 10-Q 20 May 2025
Q4 2024 -$4.84M -$3.21M -196% 31 Dec 2024 10-Q 20 May 2025
Q3 2024 -$5.03M -$3.58M -246% 30 Sep 2024 10-Q 20 May 2025
Q2 2024 -$5.48M -$4.17M -319% 30 Jun 2024 10-Q 20 May 2025
Q1 2024 -$1.38M +$2.81M +67.1% 31 Mar 2024 10-Q 20 May 2025
Q4 2023 -$1.64M +$1.75M +51.6% 31 Dec 2023 10-Q 20 May 2025
Q3 2023 -$1.45M +$960K +39.8% 30 Sep 2023 10-Q 20 May 2025
Q2 2023 -$1.31M +$102K +7.24% 30 Jun 2023 10-Q 20 May 2025
Q1 2023 -$4.19M -$3.83M -1063% 31 Mar 2023 10-Q 20 May 2024
Q4 2022 -$3.39M -$2.95M -672% 31 Dec 2022 10-Q 20 May 2024
Q3 2022 -$2.41M -$2.17M -906% 30 Sep 2022 10-Q 20 May 2024
Q2 2022 -$1.41M -$1.35M -2444% 30 Jun 2022 10-K 16 Oct 2024
Q1 2022 -$360K -$1.01M -155% 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$439K +$2M +82% 31 Dec 2021 10-Q 15 May 2023
Q3 2021 -$240K +$4.03M +94.4% 30 Sep 2021 10-Q 15 May 2023
Q2 2021 -$55.4K +$3.98M +98.6% 30 Jun 2021 10-K 13 Oct 2023
Q1 2021 $652K 31 Mar 2021 10-Q 23 May 2022
Q4 2020 -$2.44M 31 Dec 2020 10-Q 22 Feb 2022
Q3 2020 -$4.27M 30 Sep 2020 10-Q 22 Feb 2022
Q2 2020 -$4.04M -$260K -6.87% 30 Jun 2020 10-K 13 Oct 2022
Q2 2019 -$3.78M 30 Jun 2019 10-K 13 Oct 2021
Q3 2014 -$3.03M -$365K -13.7% 31 Oct 2014 10-K 01 Feb 2021
Q2 2014 -$2.68M -$70.8K -2.71% 31 Jul 2014 10-Q 01 Feb 2021
Q1 2014 -$2.97M -$373K -14.3% 30 Apr 2014 10-Q 01 Feb 2021
Q4 2013 -$2.86M -$560K -24.4% 31 Jan 2014 10-Q 01 Feb 2021
Q3 2013 -$2.67M -$567K -27% 31 Oct 2013 10-K 01 Feb 2021
Q2 2013 -$2.61M 31 Jul 2013 10-Q 01 Feb 2021
Q1 2013 -$2.6M -$788K -43.6% 30 Apr 2013 10-Q 01 Feb 2021
Q4 2012 -$2.3M -$278K -13.7% 31 Jan 2013 10-Q 01 Feb 2021
Q3 2012 -$2.1M +$472K +18.3% 31 Oct 2012 10-K 01 Feb 2021
Q1 2012 -$1.81M 30 Apr 2012 10-Q 19 Jun 2012
Q4 2011 -$2.02M 31 Jan 2012 10-Q 21 Mar 2012
Q3 2011 -$2.57M +$778K +23.2% 31 Oct 2011 10-K 01 Feb 2021
Q2 2011 -$2.37M 31 Jul 2011 10-Q/A 12 Oct 2011
Q3 2010 -$3.35M 31 Oct 2010 10-K 01 Feb 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.